SCHEMBL8749325

SCHEMBL8749325

CC(C)(C)OC(=O)N1CCC[C@H]1c1nc2ccc(-c3ccc(-c4ccc(-c5cnc([C@@H]6CCCN6)[nH]5)cc4)cc3)cc2[nH]1

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 12/20 0.44
HCRTR2 O43614 12/20 0.44
SCN10A Q9Y5Y9 1/20 0.44
CYP3A4 P08684 2/20 0.43
CYP2C9 P11712 2/20 0.43
NR1I2 O75469 1/20 0.43
ABCB11 O95342 1/20 0.43
OPRK1 P41145 1/20 0.43
KCNH2 Q12809 1/20 0.43
PRCP P42785 3/20 0.42
CHEK2 O96017 1/20 0.42
HPGDS O60760 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10201491 0.97 SCN10A (0.46) HCRTR1HCRTR2SCN10ACYP3A4CYP2C9
SCHEMBL12075270 0.92 SCN10A (0.44) HCRTR1HCRTR2SCN10ACYP3A4CYP2C9
SCHEMBL19339621 0.92 SCN10A (0.52) HCRTR1HCRTR2SCN10ACHEK2
SCHEMBL13192598 0.92 CYP3A4 (0.50) HCRTR1HCRTR2CYP3A4CYP2C9NR1I2
SCHEMBL10092391 0.92 CYP3A4 (0.50) HCRTR1HCRTR2CYP3A4CYP2C9NR1I2
SCHEMBL10125969 0.92 CYP3A4 (0.50) HCRTR1HCRTR2CYP3A4CYP2C9NR1I2
SCHEMBL2708770 0.92 CYP3A4 (0.50) HCRTR1HCRTR2CYP3A4CYP2C9NR1I2
SCHEMBL10092587 0.92 CYP3A4 (0.50) HCRTR1HCRTR2CYP3A4CYP2C9NR1I2
SCHEMBL19339652 0.90 NR1I2 (0.42) HCRTR1HCRTR2SCN10ACYP3A4CYP2C9
SCHEMBL690388 0.89 CYP3A4 (0.52) HCRTR1HCRTR2CYP3A4CYP2C9NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012068234-A2 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2012-05-24 WO disclosed
WO-2010096302-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-08-26 WO disclosed